Information de reference pour ce titreAccession Number: | 00000779-201004260-00008.
|
Author: | Briesacher, Becky A. PhD; Soumerai, Stephen B. ScD; Field, Terry S. DSc; Fouayzi, Hassan MS; Gurwitz, Jerry H. MD
|
Institution: | Author Affiliations: Division of Geriatric Medicine (Drs Briesacher, Field, and Gurwitz) and Department of Medicine and Meyers Primary Care Institute (Drs Briesacher, Field, and Gurwitz and Mr Fouayzi), University of Massachusetts Medical School, Worcester; and Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts (Dr Soumerai).
|
Title: | |
Source: | Archives of Internal Medicine. 170(8):693-698, April 26, 2010.
|
Abstract: | Background: Medicare Part D excludes benzodiazepine medications from coverage, and some state Medicaid programs also limit coverage. We assessed whether such policies decrease the risk of fractures in elderly individuals living in nursing homes.
Methods: This is a quasi-experimental study with interrupted time-series estimation and extended Cox proportional hazards models comparing changes in outcomes before and after implementation of Medicare Part D in a nationwide sample of nursing home residents in 48 states. The study included 1 068 104 residents and a subsample of 50 874 residents with fracture data from 1 pharmacy. We assessed monthly prescribing rates of benzodiazepines and potential substitutes from January 1, 2005, through June 30, 2007, and hazard ratios for incident hip fracture and falls, adjusted for age, sex, and race/ethnicity. Estimates were stratified by concurrent Medicaid limits on benzodiazepines: no supplemental coverage (1 state), partial supplemental coverage (6 states), or complete supplemental coverage (41 states).
Results: The no-supplemental-coverage policy resulted in an immediate and significant reduction of 10 absolute points in benzodiazepine use (27.0% to 17.0%) after Medicare Part D was implemented (95% confidence interval, -0.11 to -0.09; P < .001). Benzodiazepine use remained stable in the partial-supplemental- and complete-supplemental-coverage states. Hazard ratios for incident hip fracture were 1.60 (95% confidence interval, 1.05 to 2.45; P = .03) in the no-supplemental-coverage state after Medicare Part D implementation and 1.17 (95% confidence interval, 0.93 to 1.46; P = .18) in the partial-supplemental-coverage states, relative to complete-supplemental-coverage states.
Conclusion: Supplemental drug coverage exclusion policies affect the medication use of nursing home residents and may not decrease their fracture risk.
Copyright 2010 by the American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use. American Medical Association, 515 N. State St, Chicago, IL 60610.
|
Author Keywords: | Aged; Benzodiazepines; Drug Therapy; Fractures, Bone; Insurance Coverage; Medicare Part D; Nursing Homes; Patient Safety; Risk Factors.
|
References: | 1. Voyer P, Verreault R, Mengue PN, Laurin D, Rochette L, Martin LS. Managing disruptive behaviors with neuroleptics: treatment options for older adults in nursing homes. J Gerontol Nurs. 2005;31(11):49-61.
2. Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331(7526):1169.
3. Granek E, Baker SP, Abbey H, et al. Medications and diagnoses in relation to falls in a long-term care facility. J Am Geriatr Soc. 1987;35(6):503-511.
4. Mustard CA, Mayer T. Case-control study of exposure to medication and the risk of injurious falls requiring hospitalization among nursing home residents. Am J Epidemiol. 1997;145(8):738-745.
5. Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA. 1989;262(23):3303-3307.
6. Thapa PB, Gideon P, Fought RL, Ray WA. Psychotropic drugs and risk of recurrent falls in ambulatory nursing home residents. Am J Epidemiol. 1995;142(2):202-211.
7. Bambauer KZ, Sabin JE, Soumerai SB. The exclusion of benzodiazepine coverage in Medicare: simple steps for avoiding a public health crisis. Psychiatr Serv. 2005;56(9):1143-1146.
8. Uhlenhuth EH, Starcevic V, Qualls C, et al. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs. J Clin Psychopharmacol. 2006;26(5):519-523.
9. Cantopher T, Olivieri S, Cleave N, Edwards JG. Chronic benzodiazepine dependence: a comparative study of abrupt withdrawal under propranolol cover versus gradual withdrawal. Br J Psychiatry. 1990;156406-411.
10. Wagner AK, Ross-Degnan D, Gurwitz JH, et al. Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates. Ann Intern Med. 2007;146(2):96-103.
11. Briesacher BA, Soumerai SB, Field TS, Fouayzi H, Gurwitz JH. Nursing home residents and Medicare Part D enrollment. J Am Geriatr Soc. 2009;57(10):1902-1907.
12. Rahman AN, Applebaum RA. The nursing home Minimum Data Set assessment instrument: manifest functions and unintended consequences-past, present, and future. Gerontologist. 2009;49(6):727-735.
13. Doshi JA, Shaffer T, Briesacher BA. National estimates of medication use in nursing homes: findings from the 1997 Medicare current beneficiary survey and the 1996 medical expenditure survey. J Am Geriatr Soc. 2005;53(3):438-443.
14. Ross-Degnan D, Simoni-Wastila L, Brown JS, et al. A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a Medicaid population. Int J Psychiatry Med. 2004;34(2):103-123.
15. Del Rio RA, Goldman M, Kapella BK, Sulit L, Murray PK. The accuracy of Minimum Data Set diagnoses in describing recent hospitalization at acute care facilities. J Am Med Dir Assoc. 2006;7(4):212-218.
16. Hill-Westmoreland EE, Gruber-Baldini AL. Falls documentation in nursing homes: agreement between the minimum data set and chart abstractions of medical and nursing documentation. J Am Geriatr Soc. 2005;53(2):268-273.
17. Shadish WR, Cook TD, Campbell DT. Experimental and Quasi-Experimental Designs for Generalized Causal Inference. Boston, MA: Houghton Mifflin Co; 2002
18. Kleinbaum DG, Klein M. Survival Analysis: A Self-Learning Text. 2nd ed. New York, NY: Springer Publishing Co LLC; 2005
19. Ensrud KE, Blackwell T, Mangione CM, et al. Study of Osteoporotic Fractures Research Group. Central nervous system active medications and risk for fractures in older women. Arch Intern Med. 2003;163(8):949-957.
20. Taggart HM. Do drugs affect the risk of hip fracture in elderly women? J Am Geriatr Soc. 1988;36(11):1006-1010.
21. Nevitt MC, Cummings SR, Kidd S, Black D. Risk factors for recurrent nonsyncopal falls: a prospective study. JAMA. 1989;261(18):2663-2668.
22. Grisso JA, Kelsey JL, Strom BL, et al. The Northeast Hip Fracture Study Group. Risk factors for falls as a cause of hip fracture in women. N Engl J Med. 1991;324(19):1326-1331.
23. Liu BA, Topper AK, Reeves RA, Gryfe C, Maki BE. Falls among older people: relationship to medication use and orthostatic hypotension. J Am Geriatr Soc. 1995;43(10):1141-1145.
24. Pierfitte C, Macouillard G, Thicoipe M, et al. Benzodiazepines and hip fractures in elderly people: case-control study. BMJ. 2001;322(7288):704-708.
25. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716-2724.
|
Language: | English.
|
Document Type: | Original Investigation: HEALTH CARE REFORM.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0003-9926
|
NLM Journal Code: | 0372440, 7fs
|
Annotation(s) | |
|
|